DEFEAT MSA: JOSEPH G. FORTIER FOUNDATION FOR MSA – Trademark Portfolio
Entity Type: 03
DEFEAT MSA: JOSEPH G. FORTIER FOUNDATION FOR MSA holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include DEFEAT MSA MULTIPLE SYSTEM ATROPHY ADVANCEMENT AWARENESS ALLEVIATION. The owner is based in St. Clair Shores, MI.
29924 Jefferson Avenue
St. Clair Shores, MI 48082
Showing of trademarks Trademarks
Trademark Classifications
DEFEAT MSA: JOSEPH G. FORTIER FOUNDATION FOR MSA's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does DEFEAT MSA: JOSEPH G. FORTIER FOUNDATION FOR MSA have?
DEFEAT MSA: JOSEPH G. FORTIER FOUNDATION FOR MSA has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does DEFEAT MSA: JOSEPH G. FORTIER FOUNDATION FOR MSA file in?
DEFEAT MSA: JOSEPH G. FORTIER FOUNDATION FOR MSA files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are DEFEAT MSA: JOSEPH G. FORTIER FOUNDATION FOR MSA's most well-known trademarks?
DEFEAT MSA: JOSEPH G. FORTIER FOUNDATION FOR MSA's registered trademark portfolio includes well-known marks such as DEFEAT MSA MULTIPLE SYSTEM ATROPHY ADVANCEMENT AWARENESS ALLEVIATION. These are among 1 currently registered trademark in the portfolio.
What is DEFEAT MSA: JOSEPH G. FORTIER FOUNDATION FOR MSA's trademark registration success rate?
DEFEAT MSA: JOSEPH G. FORTIER FOUNDATION FOR MSA has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.